{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:23:09Z","timestamp":1793330589533,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T00:00:00Z","timestamp":1279238400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hematopoietic stem cell transplantation (HSCT) is the only curative treatment available to severe thalassemic patients. The treatment, however, is very costly, particularly in the context of low and middle income countries, and no studies have been carried out to explore its economic justifiability. This study aimed to estimate the cost-utility of HSCT compared with blood transfusions combined with iron chelating therapy (BT-ICT) for severe thalassemia in Thailand, and to investigate the affordability of HSCT using a budget impact analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A Markov model was used to estimate the relevant costs and health outcomes over the patients' lifetimes taking a societal perspective as recommended by Thailand's health technology assessment guidelines. All future costs and outcomes were discounted at a rate of 3% per annum. Primary outcomes of interest were lifetime costs, quality adjusted life years (QALYs) gained, and the incremental cost-effectiveness ratio (ICER) in Thai baht (THB) per QALY gained.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared to BT-ICT, the incremental cost-effectiveness ratio increased with patient age from 80,700 to 183,000 THB per QALY gained for related HSCT and 209,000 to 953,000 THB per QALY gained for unrelated HSCT among patients aged 1 to 15 years (US$1= 34 THB). The governmental budget impact analysis showed that providing 200 related HSCT to patients aged 1 to 10 years, in accordance with the current infrastructure limitations, would initially require approximately 90 million additional THB per year.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>At a societal willingness to pay of 100,000 THB per QALY gained, related HSCT was likely to be a cost-effective and affordable treatment for young children with severe thalassemia in Thailand.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1472-6963-10-209","type":"journal-article","created":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T06:14:36Z","timestamp":1279260876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand"],"prefix":"10.1186","volume":"10","author":[{"given":"Pattara","family":"Leelahavarong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usa","family":"Chaikledkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suradej","family":"Hongeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijj","family":"Kasemsup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoel","family":"Lubell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yot","family":"Teerawattananon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,16]]},"reference":[{"key":"1346_CR1","volume-title":"National Conference on Thalassemia 11st; Miracle Grand Hotel, Bangkok","author":"V Tienthavorn","year":"2005","unstructured":"Tienthavorn V, Patrakulvanish S, Pattanapongthorn J, Voramongkol N, Sangoarnsermsri T, Charoenkwan P: Prevalence of thalassemia carrier and risk of spouse to have a severe thalassemic child in Thailand. National Conference on Thalassemia 11st; Miracle Grand Hotel, Bangkok. 2005, Department of Health, Ministry of Public Health, Thalassemia Foundation of Thailand"},{"key":"1346_CR2","volume-title":"Master's thesis. Mahidol, Pharmacy","author":"S Bunyadharokul","year":"2008","unstructured":"Bunyadharokul S: Budget impact of the thalassemia management under the National Health Security Scheme. Master's thesis. Mahidol, Pharmacy. 2008"},{"key":"1346_CR3","volume-title":"Health-related quality of life and satisfaction with health service of thalassemia patients","author":"J Mahityutthana","year":"2007","unstructured":"Mahityutthana J: Health-related quality of life and satisfaction with health service of thalassemia patients. 2007, Master's thesis. Mahidol University, Faculty of Pharmacy"},{"key":"1346_CR4","volume-title":"Cost of illness, satisfaction and health related quality of life of thalassemia patients","author":"K Torcharus","year":"2006","unstructured":"Torcharus K, Nuchprayoon I, Indaratna K, Riewpaiboon A, Thawornshareansuk M: Cost of illness, satisfaction and health related quality of life of thalassemia patients. 2006, Nonthaburi: Clinical Research Collaboration Network"},{"issue":"12","key":"1346_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJM199403243301206","volume":"330","author":"JO Armitage","year":"1994","unstructured":"Armitage JO: Bone Marrow Transplantation. N Engl J Med. 1994, 330 (12): 827-838. 10.1056\/NEJM199403243301206.","journal-title":"N Engl J Med"},{"issue":"2","key":"1346_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.blre.2007.10.001","volume":"22","author":"G Lucarelli","year":"2008","unstructured":"Lucarelli G, Gaziev J: Advances in the allogeneic transplantation for thalassemia. Blood Rev. 2008, 22 (2): 53-63. 10.1016\/j.blre.2007.10.001.","journal-title":"Blood Rev"},{"issue":"6","key":"1346_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.bbmt.2006.02.008","volume":"12","author":"S Hongeng","year":"2006","unstructured":"Hongeng S, Pakakasama S, Chuansumrit A, Sirachainan N, Kitpoka P, Udomsubpayakul U, Ungkanont A, Jootar S: Outcomes of transplantation with related- and unrelated-donor stem cells in children with severe thalassemia. Biol Blood Marrow Transplant. 2006, 12 (6): 683-687. 10.1016\/j.bbmt.2006.02.008.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"1346_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/sj.bmt.1704361","volume":"33","author":"S Hongeng","year":"2004","unstructured":"Hongeng S, Pakakasama S, Chaisiripoomkere W, Chuansumrit A, Sirachainan N, Ungkanont A, Jootar S: Outcome of transplantation with unrelated donor bone marrow in children with severe thalassaemia. Bone Marrow Transplant. 2004, 33 (4): 377-379. 10.1038\/sj.bmt.1704361.","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"1346_CR9","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ajh.21002","volume":"82","author":"S Hongeng","year":"2007","unstructured":"Hongeng S, Pakakasama S, Chuansumrit A, Sirachainan N, Sura T, Ungkanont A, Chuncharunee S, Jootar S, Issaragisil S: Reduced intensity stem cell transplantation for treatment of class 3 Lucarelli severe thalassemia patients. Am J Hematol. 2007, 82 (12): 1095-1098. 10.1002\/ajh.21002.","journal-title":"Am J Hematol"},{"issue":"1","key":"1346_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1524-4733.2006.00145.x","volume":"10","author":"Y Teerawattananon","year":"2007","unstructured":"Teerawattananon Y, Mugford M, Tangcharoensathien V: Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Value Health. 2007, 10 (1): 61-72. 10.1111\/j.1524-4733.2006.00145.x.","journal-title":"Value Health"},{"key":"1346_CR11","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1182\/blood.V96.13.4096","volume":"96","author":"S Davies","year":"2000","unstructured":"Davies S, Kollman C, Anasetti C: Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the National Marrow Donor Program. Blood. 2000, 96: 4096-4102.","journal-title":"Blood"},{"issue":"12","key":"1346_CR12","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1182\/blood.V99.12.4350","volume":"99","author":"G La Nasa","year":"2002","unstructured":"La Nasa G, Giardini C, Argiolu F, Locatelli F, Arras M, De Stefano P, Ledda A, Pizzati A, Sanna MA, Vacca A, et al: Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood. 2002, 99 (12): 4350-4356. 10.1182\/blood.V99.12.4350.","journal-title":"Blood"},{"issue":"suppl 2","key":"1346_CR13","first-page":"S28","volume":"91","author":"A Riewpaiboon","year":"2008","unstructured":"Riewpaiboon A: Measurement of costs. J Med Assoc Thai. 2008, 91 (suppl 2): S28-37.","journal-title":"J Med Assoc Thai"},{"issue":"suppl 2","key":"1346_CR14","first-page":"S53","volume":"91","author":"U Permsuwan","year":"2008","unstructured":"Permsuwan U, Guntawongwan K, Buddhawongsa P: Handling time in economic evaluation studies. J Med Assoc Thai. 2008, 91 (suppl 2): S53-58.","journal-title":"J Med Assoc Thai"},{"key":"1346_CR15","volume-title":"Dec 20; Jainad Narendhorn meeting room, Food and Drug Administration, Ministry of Public Health Thailand","author":"The Subcommittee for Development of the National List of Essential Medicines","year":"2007","unstructured":"The Subcommittee for Development of the National List of Essential Medicines: [The threshold at which an intervention becomes cost-effective Meeting of the Subcommittee for Development of the National List of Essential Medicine 9\/2007]. Dec 20; Jainad Narendhorn meeting room, Food and Drug Administration, Ministry of Public Health Thailand. 2007"},{"key":"1346_CR16","volume-title":"Macroeconomics and Health: Investing in Health for Economic Developement","author":"The Commission on Macroeconomics and Health","year":"2002","unstructured":"The Commission on Macroeconomics and Health: Macroeconomics and Health: Investing in Health for Economic Developement. 2002, Geneva: World Health Organization"},{"key":"1346_CR17","unstructured":"Ministry of Commerce Thailand. Report for Consumer Price Index of Thailand year 2000-2008. [2008 July 9]. [http:\/\/www.indexpr.moc.go.th\/price_present\/cpi\/data\/index_47.asp?list_month=07&list_year=2551&list_region=country]"},{"key":"1346_CR18","unstructured":"International Monetary Fund. The World Economic Outlook Database. Washington, DC: IMF Publication Services, [updated April 2008December 18,2008], [http:\/\/www.imf.org\/external\/pubs\/ft\/weo\/2008\/01\/weodata\/index.aspx]"},{"key":"1346_CR19","volume-title":"Reimbursement rate of public health facilities","author":"Ministry of Public Health","year":"2004","unstructured":"Ministry of Public Health: Reimbursement rate of public health facilities. 2004, Nonthaburi: Ministry of Public Health"},{"key":"1346_CR20","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision modelling for health economic evaluation","author":"A Briggs","year":"2006","unstructured":"Briggs A, Sculpher M, Claxton K: Decision modelling for health economic evaluation. 2006, Oxford: Oxford University Press"},{"issue":"1","key":"1346_CR21","first-page":"8","volume":"6","author":"MD Yavarian","year":"2006","unstructured":"Yavarian MD, Farsheedfar G, Karimi M, Almoazzez M, Harteveld C, Giordano P: Survival analysis of transfusion dependent beta-thalassemia major patients. J Res Health Sci. 2006, 6 (1): 8-13.","journal-title":"J Res Health Sci"},{"issue":"4","key":"1346_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/03630260701641294","volume":"31","author":"M Kosaryan","year":"2007","unstructured":"Kosaryan M, Vahidshahi K, Karami H, Forootan MA, Ahangari M: Survival of thalassemic patients referred to the Boo Ali Sina Teaching Hospital, Sari, Iran. Hemoglobin. 2007, 31 (4): 453-462. 10.1080\/03630260701641294.","journal-title":"Hemoglobin"},{"issue":"7","key":"1346_CR23","first-page":"1031","volume":"29","author":"M Roudbari","year":"2008","unstructured":"Roudbari M, Soltani-Rad M, Roudbari S: The survival analysis of beta thalassemia major patients in South East of Iran. Saudi Med J. 2008, 29 (7): 1031-1035.","journal-title":"Saudi Med J"},{"issue":"6","key":"1346_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1524-4733.2007.00200.x","volume":"10","author":"RH Osborne","year":"2007","unstructured":"Osborne RH, De Abreu Lourenco R, Dalton A, Houltram J, Dowton D, Joshua DE, Lindeman R, Ho PJ: Quality of life related to oral versus subcutaneous iron chelation: a time trade-off study. Value Health. 2007, 10 (6): 451-456. 10.1111\/j.1524-4733.2007.00200.x.","journal-title":"Value Health"},{"issue":"6","key":"1346_CR25","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1185\/03007990802077442","volume":"24","author":"J Karnon","year":"2008","unstructured":"Karnon J, Tolley K, Oyee J, Jewitt K, Ossa D, Akehurst R: Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United Kingdom. Curr Med Res Opin. 2008, 24 (6): 1609-1621. 10.1185\/03007990802077442.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"1346_CR26","first-page":"238","volume":"27","author":"L Slovacek","year":"2005","unstructured":"Slovacek L, Slovackova B, Jebavy L: Global quality of life in patients who have undergone the hematopoietic stem cell transplantation: finding from transversal and retrospective study. Exp Oncol. 2005, 27 (3): 238-242.","journal-title":"Exp Oncol"},{"issue":"suppl 2","key":"1346_CR27","first-page":"S59","volume":"91","author":"S Limwattananon","year":"2008","unstructured":"Limwattananon S: Handling uncertainty of the economic evaluation result: sensitivity analysis. J Med Assoc Thai. 2008, 91 (suppl 2): S59-S65.","journal-title":"J Med Assoc Thai"},{"key":"1346_CR28","unstructured":"International Monetary Fund. The World Economic Outlook Database. Washington, DC: IMF Publication Services, [2008 December 18], [http:\/\/www.imf.org\/external\/pubs\/ft\/weo\/2008\/01\/weodata\/index.aspx]"},{"key":"1346_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1196\/annals.1345.024","volume":"1054","author":"J Gaziev","year":"2005","unstructured":"Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G: Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up. Ann N Y Acad Sci. 2005, 1054: 196-205. 10.1196\/annals.1345.024.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"1346_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1046\/j.1365-2141.2003.04065.x","volume":"120","author":"SE Lawson","year":"2003","unstructured":"Lawson SE, Roberts IA, Amrolia P, Dokal I, Szydlo R, Darbyshire PJ: Bone marrow transplantation for beta-thalassaemia major: the UK experience in two paediatric centres. Br J Haematol. 2003, 120 (2): 289-295. 10.1046\/j.1365-2141.2003.04065.x.","journal-title":"Br J Haematol"},{"issue":"5","key":"1346_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/bmt.2008.165","volume":"42","author":"DK Cheuk","year":"2008","unstructured":"Cheuk DK, Mok AS, Lee AC, Chiang AK, Ha SY, Lau YL, Chan GC: Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant. 2008, 42 (5): 319-327. 10.1038\/bmt.2008.165.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"1346_CR32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1046\/j.1365-2141.2000.02053.x","volume":"110","author":"S Chiodi","year":"2000","unstructured":"Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, et al: Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol. 2000, 110 (3): 614-619. 10.1046\/j.1365-2141.2000.02053.x.","journal-title":"Br J Haematol"},{"issue":"7","key":"1346_CR33","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1524-4733.2008.00321.x","volume":"11","author":"V Kasemsup","year":"2008","unstructured":"Kasemsup V, Schommer JC, Cline RR, Hadsall RS: Citizen's preferences regarding principles to guide health-care allocation decisions in Thailand. Value Health. 2008, 11 (7): 1194-1202. 10.1111\/j.1524-4733.2008.00321.x.","journal-title":"Value Health"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6963-10-209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6963-10-209\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6963-10-209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6963-10-209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T11:43:43Z","timestamp":1711626223000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/1472-6963-10-209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,16]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1346"],"URL":"https:\/\/doi.org\/10.1186\/1472-6963-10-209","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,16]]},"assertion":[{"value":"12 November 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"209"}}